83 related articles for article (PubMed ID: 21855131)
1. Inflammatory responses to pulmonary application of PEI-based siRNA nanocarriers in mice.
Beyerle A; Braun A; Banerjee A; Ercal N; Eickelberg O; Kissel TH; Stoeger T
Biomaterials; 2011 Nov; 32(33):8694-701. PubMed ID: 21855131
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vivo study of poly(ethylene imine)/siRNA complexes for pulmonary delivery in mice.
Beyerle A; Braun A; Merkel O; Koch F; Kissel T; Stoeger T
J Control Release; 2011 Apr; 151(1):51-6. PubMed ID: 21223987
[TBL] [Abstract][Full Text] [Related]
3. Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance.
Merkel OM; Beyerle A; Librizzi D; Pfestroff A; Behr TM; Sproat B; Barth PJ; Kissel T
Mol Pharm; 2009; 6(4):1246-60. PubMed ID: 19606864
[TBL] [Abstract][Full Text] [Related]
4. Poly(ethylene imine) nanocarriers do not induce mutations nor oxidative DNA damage in vitro in MutaMouse FE1 cells.
Beyerle A; Long AS; White PA; Kissel T; Stoeger T
Mol Pharm; 2011 Jun; 8(3):976-81. PubMed ID: 21446747
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression.
Huang HY; Kuo WT; Chou MJ; Huang YY
J Biomed Mater Res A; 2011 Jun; 97(3):330-8. PubMed ID: 21465641
[TBL] [Abstract][Full Text] [Related]
6. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
7. Toxicity pathway focused gene expression profiling of PEI-based polymers for pulmonary applications.
Beyerle A; Irmler M; Beckers J; Kissel T; Stoeger T
Mol Pharm; 2010 Jun; 7(3):727-37. PubMed ID: 20429563
[TBL] [Abstract][Full Text] [Related]
8. PEGylation affects cytotoxicity and cell-compatibility of poly(ethylene imine) for lung application: structure-function relationships.
Beyerle A; Merkel O; Stoeger T; Kissel T
Toxicol Appl Pharmacol; 2010 Jan; 242(2):146-54. PubMed ID: 19822165
[TBL] [Abstract][Full Text] [Related]
9. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
[TBL] [Abstract][Full Text] [Related]
10. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration.
de Wolf HK; Snel CJ; Verbaan FJ; Schiffelers RM; Hennink WE; Storm G
Int J Pharm; 2007 Mar; 331(2):167-75. PubMed ID: 17134859
[TBL] [Abstract][Full Text] [Related]
11. Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes.
Mao S; Neu M; Germershaus O; Merkel O; Sitterberg J; Bakowsky U; Kissel T
Bioconjug Chem; 2006; 17(5):1209-18. PubMed ID: 16984130
[TBL] [Abstract][Full Text] [Related]
12. 1,4-Butanediol diglycidyl ether (BDE)-crosslinked PEI-g-imidazole nanoparticles as nucleic acid-carriers in vitro and in vivo.
Goyal R; Bansal R; Tyagi S; Shukla Y; Kumar P; Gupta KC
Mol Biosyst; 2011 Jun; 7(6):2055-65. PubMed ID: 21505659
[TBL] [Abstract][Full Text] [Related]
13. Polymer-related off-target effects in non-viral siRNA delivery.
Merkel OM; Beyerle A; Beckmann BM; Zheng M; Hartmann RK; Stöger T; Kissel TH
Biomaterials; 2011 Mar; 32(9):2388-98. PubMed ID: 21183213
[TBL] [Abstract][Full Text] [Related]
14. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
[TBL] [Abstract][Full Text] [Related]
15. Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity.
Zintchenko A; Philipp A; Dehshahri A; Wagner E
Bioconjug Chem; 2008 Jul; 19(7):1448-55. PubMed ID: 18553894
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.
Wang J; Feng SS; Wang S; Chen ZY
Int J Pharm; 2010 Nov; 400(1-2):194-200. PubMed ID: 20801205
[TBL] [Abstract][Full Text] [Related]
18. State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers.
Fattal E; Bochot A
Int J Pharm; 2008 Dec; 364(2):237-48. PubMed ID: 18619528
[TBL] [Abstract][Full Text] [Related]
19. A highly efficient siRNA carrier of PBLG modified hyperbranched PEI.
Chen J; Tian H; Guo Z; Xia J; Kano A; Maruyama A; Jing X; Chen X
Macromol Biosci; 2009 Dec; 9(12):1247-53. PubMed ID: 19890950
[TBL] [Abstract][Full Text] [Related]
20. siRNA transfection by dendritic core-shell nanocarriers.
Fischer W; Claderon M; Ofek P; Satchi-Fainaro R; Haag R
J Control Release; 2010 Nov; 148(1):e89. PubMed ID: 21529651
[No Abstract] [Full Text] [Related]
[Next] [New Search]
